Eribulin Mesylate

Cas No.：441045-17-6

Status：Established(USDMF,ASMF,MF)

Eribulin mesylate is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin mesylate inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.

E-mail Product Inquiry